INTERNATIONAL PATENT: GILEAD SCIENCES, INC. FILES APPLICATION FOR "COMBINATION THERAPY COMPRISING BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND P-GLYCOPROTEIN INHIBITORS"

GENEVA, April 15 -- GILEAD SCIENCES, INC. (333 Lakeside DriveFoster City, California 94404) filed a patent application (PCT/US2025/049268) for "COMBINATION THERAPY COMPRISING BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND P-GLYCOPROTEIN INHIBITORS" on Oct 02, 2025. With publication no. WO/2026/076265, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GONZALEZ BUENROSTRO, Ana Z. (c/o Gilead Sciences, Inc.333 Lakeside DriveFoster City, California 94404), JIANG, Lan (c/o Gilead Sciences, Inc.333 Lakeside DriveFoster City, C...